Thrombocytosis disease
MONDO:0002249A disease characterized by higher than normal platelet counts in the peripheral blood.
Also known as: Platelet count increased, elevated Platelet count, thrombocytosis
71 clinical trials for this condition and its sub-types, 7 tagged with Thrombocytosis disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Thrombocytosis disease
-
Essential thrombocythemia 67 trials
-
Familial thrombocytosis 2 trials
3 sub-types
- Thrombocythemia 1 0 trials
- Thrombocythemia 2 0 trials
- Thrombocythemia 3 0 trials
-
Reactive thrombocytosis 0 trials
-
New drug cocktail shows promise for Hard-to-Treat leukemia
Disease control OngoingThis early-phase trial tests a combination of three drugs—azacitidine, venetoclax, and pevonedistat—in adults newly diagnosed with a challenging form of acute myeloid leukemia (AML). The goal is to find the best dose and see if the combo can improve remission rates. About 40 part…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New hope for myelofibrosis patients who fail current treatments
Disease control OngoingThis phase 3 trial tests a drug called imetelstat against the best available treatments for people with advanced myelofibrosis whose disease has stopped responding to JAK inhibitors. The study includes 327 participants and aims to see if imetelstat can help them live longer and f…
Phase 3 • Sponsor: Geron Corporation • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC